P07477 (TRY1_HUMAN) Homo sapiens (Human)
Serine protease 1 UniProtKBInterProSTRINGInteractive Modelling
247 aa; Sequence (Fasta)
Available Structures
8 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Substrate-bound EP, polyA model |
Heteromer P98073; | 100.0 | ||||
| Human cationic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI) |
Heteromer P00974; | 99.11 | 2×CA; 24×SO4; | |||
| human cationic trypsin G193R mutant in complex with bovine pancreatic trypsin inhibitor |
Heteromer P00974; | 99.11 | 5×SO4; | |||
| Human cationic trypsin (TRY1) complexed with serine protease inhibitor Kazal type 1 N34S (SPINK1 N3… |
Heteromer P00995; | 99.55 | 3×SO4; | |||
| Human cationic trypsin K97D mutant in complex with bovine pancreatic trypsin inhibitor (BPTI) |
Heteromer P00974; | 98.66 | 1×CA; 2×SO4; | |||
| Human cationic trypsin (TRY1) complexed with serine protease inhibitor Kazal type 1 (SPINK1) |
Heteromer P00995; | 99.55 | 1×SO4; | |||
| COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG-CHLOROMETHYLKETONE | homo-2-mer | 61.91 | 2×0G6; | |||
| CRYSTAL STRUCTURE OF HUMAN TRYPSIN 1: UNEXPECTED PHOSPHORYLATION OF TYROSINE 151 | homo-2-mer | 100 | 2×ISP; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1co7.1.A | monomer | 0.89 | 1×CA; | 78.51 | ||